Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a new version of the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedEnrollment status shows no longer looking for participants, indicating recruitment has ended. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) are added, and the Intervention/Treatment heading formatting is updated, with a revision note showing Revision: v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe study page now shows revision v3.5.5 instead of v3.5.4, signaling a recent update to the record.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page version has been updated from v3.5.3 to v3.5.4, indicating a software update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 on the study documents listed on the page, representing a newer version of the protocol/document referenced.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision tag now shows v3.5.2 instead of v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.